WebJames B. Tananbaum is an American entrepreneur and businessperson who founded 9 companies, including: GelTex Pharmaceuticals, Inc., Innoviva, Inc. and Theravance Biopharma, Inc. and who has been at the head of 7 different companies. Presently, James B. Tananbaum holds the position of Chief Executive Officer & Managing Director at Foresite ... Webtarsa therapeutics, inc. This Amendment No. 1 (this “ Amendment No. 1 ”), dated as of January 15, 2010 (the “ Amendment Date ”), hereby amends that certain License Agreement, dated as of October 19, 2009 (the “ Agreement ”), by and between Unigene Laboratories, Inc. (“ Unigene ”), a Delaware corporation, and Tarsa Therapeutics, Inc. (“ Tarsa ”), a Delaware …
Peptide Drugs Market Size Global Industry Analysis and Opportunity …
Web1628 John F. Kennedy Boulevard 8 Penn Center Suite 1400 Philadelphia, Pennsylvania 19103, US WebMar 16, 2012 · PHILADELPHIA, March 16, 2012 /PRNewswire/ -- Tarsa Therapeutics, Inc. today announced completion of a $28 million Series B equity financing led by new … michigan medicine cstp
Obchod - Stránka 575 z 575 - Lekáreň IZIS
WebFeb 15, 2024 · Feb 15, 2024 (The Expresswire) -- "Oral Proteins And Peptides Market" Insights 2024 By Types, Applications, Regions and Forecast to 2029. The global Oral... WebAug 17, 2009 · Tarsa Therapeutics, Inc. ClinicalTrials.gov Identifier: NCT00959764 Other Study ID Numbers: UGL-OR0801 2008-003322-42 ( EudraCT Number ) First Posted: August 17, 2009 Key Record Dates: Results First Posted: November 19, 2013: Last Update Posted: November 19, 2013 ... WebFind the latest Protara Therapeutics, Inc. (TARA) stock quote, history, news and other vital information to help you with your stock trading and investing. michigan medicine cornerstone